Utilizing intensity modulated radiation therapy (IMRT), Riverview’s radiation oncologists have the most advanced cancer treatment option at their disposal. This state-of-the-art technology allows doctors and technicians to escalate the dose of cancer killing radiation to tumors, all while minimizing complications in surrounding healthy tissues. IMRT is the most sophisticated radiation treatment in the world for many cancers.
IMRT is used to treat patients with prostate, breast, head and neck, lung, pancreatic, and other cancers where precisely placed beams can be focused to carefully target tumor cells while protecting surrounding tissue.
With IMRT, there is a much greater chance of completely eliminating tumors and minimizing complications. Increased precision allows physicians to use radiation to treat areas that would have been considered too risky just a few years ago.
Thomas Dugan, MD, is a graduate of DePauw University. He obtained his Doctor of Medicine with Highest Distinction from Indiana University. He completed his internship at Methodist Hospital in Indianapolis and his residency in radiation oncology at the Massachusetts General Hospital in Boston. He was Chief Resident during his final year. He is board certified in radiation oncology.
Davis Ross, MD, is a graduate of George Washington University in Washington, D.C. After graduating from Medical School he did an Internship in Straight Medicine and a Residency in General Radiology at Temple University in Philadelphia, Pennsylvania followed by a Radiation Oncology Residency at Jefferson University Hospital in Philadelphia, Pennsylvania. During Dr. Ross’ tenure as a Radiation Oncologist, he has participated in many professional societies and professional committees. Dr. Ross has also participated and continues to participate in several medical research groups and has been published multiple times.
For More Information
Riverview Cancer Center
395 Westfield Road